Stock screener

HUMA

Conviction 0HealthcareScan · Tue, Sep 8, 2026
HUMA$0.5977-1.19%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell
63 bars
Vol MA14 7.46M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Humacyte, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.humacyte.com
Price0.5977
Change-1.19%
Gap+0.76%
Rel volume0.21×
Avg volume10.4M
Avg $ vol6.45M
SMA 200.6343
SMA 500.6702
SMA 2000.9366
Price vs 50-10.82%
Price vs 200-36.19%
MA stackbearish
50/200 cross
Supertrenddown · 0.7450
RSI (14)44
MACD hist-0.00
MACD crossbear · 4d
Stoch %K / %D15 / 24
ADX (14)15
+DI / −DI16 / 23
RSI divergence
MACD divergence
ATR %+9.01%
ADR %9.12%
52w high2.48
52w low0.5500
From 52w high-75.90%
Above 52w low+8.67%
New 52w highNo
SqueezeOff
Bollinger width33.57%
%B0.33
Donchian pos31.98%
Donchian high0.7500
Donchian low0.5261
AVWAP (52w high)0.9808
vs AVWAP high-39.06%
AVWAP (52w low)0.6227
vs AVWAP low-4.02%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d0.21×
Avg vol (14d)7.46M
Avg vol (20d)10.4M
Avg $ vol (20d)6.45M
Market cap166.04M
RS 3m (vs SPY)-59.62%
RS 6m (vs SPY)-60.05%
RS line new highNo
Trend template0/8
Technical rank9.7
1 week-0.62%
1 month-16.78%
3 months-56.69%
6 months-50.19%
1 year-58.20%
YTD-38.70%
P/E-4.07
P/B5.31
P/S81.47
P/FCF-1.57
EPS-0.2600
Div yield
ROE-130.62%
ROA-29.57%
Debt/Eq1.16
Current6.21
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth72.54%
Price target2.06
Target upside244.65%
Analyst ratingBuy
Institutional29.53%
Ent. value122.46M
Revenue406K
Net income-36.8M
Gross profit
Free cash flow-105.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out222.02M
Employees184
ListedFri, Aug 27, 2021
Free float196.53M
Float %88.5%
Short interest31.94M
Days to cover3.4d
Short volume69.6%
Squeeze score69 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.16 vs −$0.10
Last surprise-60.0% miss
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank9.7 / 100
Group rank96 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance0.7500
Support0.5480
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HUMA · 10 recent

All disclosures →
MemberSideAmount
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-03-21
Buy$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-03-21
Buy$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-04-30
Sell$50K–$100K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-03-21
Buy$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-03-21
Buy$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-02-12
Buy$15K–$50K

Insider activity

SEC Form 4 transactions in HUMA · 5 buys · 2 sells

InsiderSideShares
Jones Keith Anthony
Director · Common Stock · 2026-08-20
Buy10K
Jones Keith Anthony
Director · Common Stock · 2026-08-17
Buy30K
Bamforth John Philip
Director · Stock Options (right to buy) · 2026-06-11
Grant80K
Sebelius Kathleen
Director · Common Stock · 2026-05-19
Buy56.82K
Constantino Michael T.
Director · Common Stock · 2026-05-18
Buy11K
Parikh Shamik J
Chief Medical Officer · Common Stock · 2026-05-18
Sell45.89K
Sander Dale A.
CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18
Sell45.89K
Sander Dale A.
CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18
Other

SEC filings

EDGAR filings in HUMA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.